SCHEMBL11750097

SCHEMBL11750097

CC(O)CN(c1nnc(-c2ccc([S+](C)[O-])cc2)c(-c2ccc([S+](C)[O-])cc2)n1)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11746332 0.86 — —
SCHEMBL11743524 0.82 — —
SCHEMBL11747477 0.81 CYP1A2 (0.30) —
SCHEMBL11749947 0.77 NUDT1 (0.35) —
SCHEMBL11745513 0.74 CA12 (0.33) —
SCHEMBL11747582 0.74 L3MBTL1 (0.37) —
SCHEMBL11748846 0.74 POLB (0.30) —
SCHEMBL2322935 0.73 GPR84 (0.34) —
SCHEMBL11741685 0.73 MAPT (0.31) —
SCHEMBL11743535 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4008232-A ANTIINFLAMMATORY ELI LILLY AND COMPANY (US) 1977-02-15 — — US disclosed
Send feedback